StockData
Biodesix Inc logo

Biodesix Inc (BDSX) stock

BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$8.40−0.48 (-5.41%)

Close on Nov 18, 2026Market cap $88.63MP/E –Yield –

Biodesix net income

Net income is the profit left for shareholders after every expense, interest and tax.

Biodesix's net income for the twelve months ending Jun 30, 2026 was -$27.76M. For fiscal 2025 it was -$35.27M. The highest annual figure on record is -$30.73M in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$35.27M–
FY2024Dec 31, 2024-$42.93M–
FY2023Dec 31, 2023-$52.15M–
FY2022Dec 31, 2022-$65.45M–
FY2021Dec 31, 2021-$43.16M–
FY2020Dec 31, 2020-$65.45M–
FY2019Dec 31, 2019-$30.73M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.27M–
Q1 FY2026Mar 31, 2026-$7.79M–
Q4 FY2025Dec 31, 2025-$3.98M–
Q3 FY2025Sep 30, 2025-$8.72M–
Q2 FY2025Jun 30, 2025-$11.47M–
Q1 FY2025Mar 31, 2025-$11.10M–
Q4 FY2024Dec 31, 2024-$8.25M–
Q3 FY2024Sep 30, 2024-$10.26M–
Q2 FY2024Jun 30, 2024-$10.81M–
Q1 FY2024Mar 31, 2024-$13.61M–
Q4 FY2023Dec 31, 2023-$9.14M–
Q3 FY2023Sep 30, 2023-$10.95M–
Q2 FY2023Jun 30, 2023-$13.36M–
Q1 FY2023Mar 31, 2023-$18.70M–
Q4 FY2022Dec 31, 2022-$20.34M–
Q3 FY2022Sep 30, 2022-$13.70M–
Q2 FY2022Jun 30, 2022-$15.82M–
Q1 FY2022Mar 31, 2022-$15.59M–
Q4 FY2021Dec 31, 2021-$13.28M–
Q3 FY2021Sep 30, 2021-$11.51M–
Q2 FY2021Jun 30, 2021-$11.40M–
Q1 FY2021Mar 31, 2021-$6.96M–
Q4 FY2020Dec 31, 2020-$38.63M–
Q3 FY2020Sep 30, 2020-$8.85M–
Q2 FY2020Jun 30, 2020-$8.27M–
Q1 FY2020Mar 31, 2020-$9.71M–
Q4 FY2019Dec 31, 2019-$6.53M–
Q3 FY2019Sep 30, 2019-$9.60M–
Q2 FY2019Jun 30, 2019-$6.86M–
Q1 FY2019Mar 31, 2019-$7.74M–

More Biodesix figures

See a number that looks wrong?